Form 4: Achieve Life Sciences Executive Chairman Richard Stewart Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Richard Stewart, Executive Chairman of Achieve Life Sciences, reports the acquisition of 22,500 shares of common stock upon settlement of performance restricted stock units and the disposal of 10,125 shares to cover tax liabilities.

Summary

  • On April 19, 2024, Richard Stewart, the Executive Chairman of Achieve Life Sciences, engaged in transactions involving the company's common stock.
  • He acquired 22,500 shares of common stock upon the settlement of performance restricted stock units (PRSUs).
  • Concurrently, he disposed of 10,125 shares to satisfy tax liabilities associated with the PRSU settlement at a price of $4.51 per share.
  • Following these transactions, Stewart directly owns 50,876 shares of Achieve Life Sciences common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reflects standard executive compensation practices and tax obligations.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders by slightly diluting the stock due to the issuance of shares from PRSU settlement, offset by the sale of shares to cover tax obligations.

Key Dates

DateDescription
04/19/2024Date of stock acquisition and disposal transactions.
04/23/2024Date of signature on the Form 4 filing.
01/03/2026Expiration date of the Performance Restricted Stock Units (PRSUs).

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.